Alexandra Albertsson Lindblad

Sökresultat

• 2024

  Clinical characteristics and outcomes of 476 mantle cell lymphoma patients aged 80 years and older

  Pahnke, S., Abalo, K. D., Ekberg, S., Albertsson-Lindblad, A., E. Smedby, K., Jerkeman, M. & Glimelius, I., 2024 dec., I: Blood Cancer Journal. 14, 1, 222.

  Forskningsoutput: Tidskriftsbidrag › Letter › Peer review

  Öppen tillgång
• 2022

  Survival in mantle cell lymphoma after frontline treatment with R-bendamustine, R-CHOP and the Nordic MCL2 regimen - a real world study on patients diagnosed in Sweden 2007-2017

  Albertsson Lindblad, A., Palsdottir, T., Smedby, K. E., Weibull, C. E., Glimelius, I. & Jerkeman, M., 2022, I: Haematologica. 107, 3, s. 740-743

  Forskningsoutput: Tidskriftsbidrag › Letter › Peer review

  Öppen tillgång
• 2018

  Lenalidomide plus bendamustine-rituximab does not overcome the adverse impact of TP53 mutations in mantle cell lymphoma

  Eskelund, C. W., Albertsson-Lindblad, A., Kolstad, A., Laurell, A., Räty, R., Pedersen, L. B., Geisler, C. H., Jerkeman, M. & Grønbæk, K., 2018, I: Haematologica. 103, 11, s. e541-e543

  Forskningsoutput: Tidskriftsbidrag › Letter › Peer review

  Öppen tillgång